25 related articles for article (PubMed ID: 38660802)
21. Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease.
Xu N; Alfieri CM; Yu Y; Guo M; Yutzey KE
Arterioscler Thromb Vasc Biol; 2024 Apr; ():. PubMed ID: 38660802
[TBL] [Abstract][Full Text] [Related]
22. Pathology of myxomatous mitral valve disease in the dog.
Fox PR
J Vet Cardiol; 2012 Mar; 14(1):103-26. PubMed ID: 22386587
[TBL] [Abstract][Full Text] [Related]
23. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
[TBL] [Abstract][Full Text] [Related]
24. Mitral valve disease in Marfan syndrome and related disorders.
Judge DP; Rouf R; Habashi J; Dietz HC
J Cardiovasc Transl Res; 2011 Dec; 4(6):741-7. PubMed ID: 21866385
[TBL] [Abstract][Full Text] [Related]
25. Signaling pathways in mitral valve degeneration.
Orton EC; Lacerda CM; MacLea HB
J Vet Cardiol; 2012 Mar; 14(1):7-17. PubMed ID: 22364692
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]